GIMV - belgischer VC/PE-Investor - 500 Beiträge pro Seite

[R-BgO]

...zahlt aktuell knapp 6% Dividende;

watchlist

[R-BgO]

Webseite: http://www.gimv.com/view/en/387051-+About+Gimv+.html

[R-BgO]

Exit bei einem Beteiligungsunternehmen, sogar ein IPO

Thread: McPhy - französischer Wasserstoff-Speicher-Hersteller

[R-BgO]

Press Release - Antwerp, 22 May 2014
Gimv posts EUR 15.0 million profit for the year, giving a net asset value of EUR 40.12 per share - Major investment activity (EUR 194.6 million) across all platforms - Gross dividend stable at EUR 2.45 - with optional dividend

Topic: Annual report

The results for the 2013-2014 financial year cover the period from 1 April 2013 to 31 March 2014.

Highlights (consolidated figures)

Results
• Net result (group’s share) EUR 15.0 million (EUR 0.61 per share)
• Net realised capital gains: EUR 7.9 million
• Net unrealised capital gains: EUR 3.3 million

Equity (at 31.03.2014)
• Equity value (group’s share): EUR 992.0 million (EUR 40.12 per share)

Dividend
• Dividend for the 2013-2014 financial year: EUR 60.6 million, or EUR 2.45 gross (EUR 1.84 net) per share (subject to approval by the AGM of 25 June 2014). To strengthen Gimv's further growth and its investment activities, an optional dividend will be offered again this year.

Balance sheet (at 31.03.2014)
• Balance sheet total: EUR 1 026.7 million
• Net cash position: EUR 56.6 million.
• Financial assets: EUR 931.0 million.

Investments
• Total investments (on balance sheet): EUR 194.6 million (EUR 49.2 million in the fourth quarter). Additional investments via co-investment funds: EUR 70.2 million (EUR 27.5 million in the fourth quarter).
Total investments (on balance sheet & via co-investment funds): EUR 264.8 million (EUR 76.7 million in the fourth quarter).

Divestments
• Total divestment revenues (on balance sheet): EUR 95.8 million (EUR 17.6 million in the fourth quarter).
Additional revenue from divestments via co-investment funds: EUR 35.3 million (EUR 2.9 million in the fourth quarter). Total divestments (on balance sheet & via co-investment funds): EUR 131.1 million (EUR 20.5 million in the fourth quarter).
• Divestment revenues: 10.5% above equity carrying value at 31 March 2013, and at a multiple of 0.94x original acquisition value.


Commentary

Managing Director Koen Dejonckheere, on the past financial year's results: "Gradually we are seeing signs that the European economy has been coming out of recession since the second half of 2013, slowed somewhat by measures many European countries are having to take to bring their budgets back into balance, and which weigh on companies’ growth and profitability. On the other hand, we find that company balance sheets are quietly becoming healthy again and quite a few companies are targeting international growth markets. Moreover, confidence in the equity markets has returned, as also reflected in the revival of IPOs. " He continues: "The past year was marked by a historically high investment activity, with Gimv entering no less than twelve new long-term partnerships with promising companies and selectively investing in the further development of the various platforms. In the case of Electrawinds we have turned the page and have joined in a scenario that provides continuity for both the company and the employees involved. This particular case does not, however, weaken Gimv's commitment towards the renewable energy sector."

Chairman Urbain Vandeurzen adds: "In September 2012, Gimv launched its platform strategy. Focused on value creation, this states our ambition to be the reference in a number of carefully selected investment platforms. Two years later, entrepreneurs focused on innovation, internationalization and expansion are finding their way to Gimv's door. This has doubled of the number of new investments, selected as responding to a number of crucial societal challenges and long-term trends. The Gimv Health & Care Fund that Gimv launched last year with a number of stakeholders also meets these challenges. In recent months, the fund has entered promising partnerships with two innovative companies and service providers in the health & care sector. " He continues: "To finance the further expansion of the portfolio and the growth of Gimv, we are again offering our shareholders this year a stable dividend with the possibility of opting for a stock dividend."

[R-BgO]

09-06-2014 08:00

Gimv sells its 9.6%-stake in Barco to international technology company Van de Wiele, which gives Barco the guarantee to further build its technological leadership.

Gimv sells its 9.6%-stake in Barco to Van de Wiele Group, a leading international technology company and excellent example of the Flemish manufacturing industry.

Gimv and Barco have a long common history dating back to the early 80s. With the Van de Wiele Group, Barco again obtains a sustainable long-term shareholder, which offers the company the best guarantee to continue the global expansion of its technological leadership.

Gimv will use the proceeds for future investments in new leading growth companies.

The agreed price structure has no material impact on the current book value of Gimv.

[R-BgO]

Press Release - Antwerp, 08 July 2014
Gimv sells its stake in Movea

Topic: Divestment

Gimv is selling its stake in Movea to InvenSense Inc. (NYSE: INVN), the leading provider of intelligent sensor solutions for consumer electronic devices. Gimv entered the French start-up in 2007. Since then, it has become a recognised leader on the data fusion and motion processing technologies market.

In the past seven years, Gimv has been involved in three financing rounds of Movea (www.movea.com) and notably, supported the takeover of the American company Gyration. This transaction enabled Movea to make the switch to consumer electronics, providing it with know-how in consumer products. Having sold Gyration in 2011 to concentrate on its core activity, Movea has become a reference player on the data fusion and motion processing technologies market.

Based in Grenoble (France), Movea was founded in March 2007 as a spin-off of the French research institute CEA-Léti. It develops data fusion and motion processing technologies (firmware, software, IP) for tracking physical/personal activities (sport/keep fit/e-health) and electronic consumer products (smartphones, tablets, smart TVs, etc.). The company transforms data from sensors into intelligible personal information (localisation of user, tracking activity and sensitivity to context). Its technology is protected by over 500 patents and makes it possible to reduce costs and energy consumption of products whilst increasing their precision. Its current partners and customers include: Samsung, STMicroelectronics, Orange, Babolat, Décathlon, Philips, Texas Instruments a.o.

Geoffroy Dubus, Partner at Gimv, comments: "As primary shareholder, we are proud of having supported Movea's success and its positioning on the consumer, mobile and entertainment markets, areas which are expanding."

The sale of Movea has had a positive impact of EUR 5.2 million (EUR 0.21 per share) on Gimv's equity value published on 31 March 2014. Throughout the whole period, this investment generated an IRR higher than Gimv's average IRR. No further financial details will be published about this transaction.

Its takeover by InvenSense Inc. shall enable Movea to complete a new stage in its growth. InvenSense Inc. is the leading provider of intelligent motion and sound sensor solutions for consumer electronic devices such as smartphones, tablets, wearables, gaming devices, optical image stabilization, and remote controls for Smart TVs. The company’s MotionTracking™ products are also being integrated into a number of industrial applications. The company’s patented InvenSense Fabrication Platform and patent-pending MotionFusion™ technology address the emerging needs of many mass-market consumer applications via improved performance, accuracy, and intuitive motion-, gesture- and sound-based interfaces.

[R-BgO]

Press Release - Antwerp, 25 August 2014
Gimv: Erfolgreicher Exit des Portfolio-Unternehmens Covagen

Topic: Divestment

Gimv Die europäische Beteiligungsgesellschaft Gimv (www.gimv.com) gibt heute den erfolgreichen Verkauf des Schweizer Unternehmens Covagen AG (www.covagen.com) aus ihrem Portfolio an die Cilag GmbH International bekannt. Der Käufer gehört zu Janssen, der pharmazeutischen Sparte von Johnson & Johnson (www.jnj.de). Covagen entwickelt neuartige Pharmazeutika für die Behandlung von Krebs und Entzündungskrankheiten.

Gimv führte im Dezember 2013 eine Serie-B-Finanzierungsrunde in Höhe von 42,0 Mio. CHF für Covagen an. Die Beteiligungsgesellschaft sagte 8,3 Mio. CHF zu und war damit an einer von Europas größten privaten Finanzierungsrunden für ein Biotechnologieunternehmen im präklinischen Stadium beteiligt. Im Rahmen dieser Transaktion ist Dr. Nägler, Partner Health & Care bei Gimv, dem Verwaltungsrat der Covagen beigetreten und hat später dessen Vorsitz übernommen.

Gemessen an den Vorauszahlungen nach Abzug der Provisionen hat der Verkauf einen positiven Einfluss in Höhe von 14,8 Mio. EUR (0,58 EUR/Anteil) auf den Kapitalwert von Gimv, den das Unternehmen am 30. Juni 2014 veröffentlicht hat. In Relation zur Anlagedauer liegt diese Rendite deutlich über dem historischen Durchschnitt von Gimv.

Weitere Details der Transaktion werden nicht veröffentlicht.

2007 als Ausgliederung der ETH Zürich in der Schweiz gegründet, entwickelt Covagen heute auf der Basis ihrer patentierten Fynomer®-Technologie eine Plattform für Medikamente zur Behandlung von Krebs und Entzündungskrankheiten.

Dr. Karl Nägler, Partner Health & Care bei Gimv, kommentiert die Transaktion: „Wir kennen Covagen und das Management-Team seit mehr als sechs Jahren. Seit 2008 verfolgen wir schon den erfolgreichen Weg des Unternehmens. Wir sind stolz, nach dieser langen Partnerschaft an diesem Erfolg beteiligt zu sein.“

Die Pressemitteilung der zu Janssen/Johnson & Johnson gehörenden Cilag GmbH International finden Sie hier: http://www.prnewswire.com/news-releases/janssen-affiliate-ci…

[R-BgO]

Gimv investiert in EcoChem International, Hersteller von Spezialchemie-Formulierungen

Topic: Investment

Gimv investiert in EcoChem International, einen belgischen Spezialisten für umweltfreundliche, flammhemmende Additive, der in diesem Bereich die gesamte Prozesskette abdeckt – von Innovation über Produktentwicklung und Fertigung bis zur Vermarktung. Gimv erwirbt eine Mehrheitsbeteiligung und ist damit neben den Gründern als Haupteigentümer vertreten. EcoChem nutzt die neue Finanzierung für seine ehrgeizige Wachstumsstrategie, die das Unternehmen sowohl über eine internationale Expansion als auch über den Einstieg in neue Produktsegmente verfolgt.

EcoChem (www.ecochem.be) konzentriert sich auf die Entwicklung und Formulierung von umweltfreundlichen, flammhemmenden Additiven, die vorwiegend in den Sektoren Hoch- und Tiefbau, Transport und in der Elektrotechnik zum Einsatz kommen. Die Produkte des Unternehmens werden Werkstoffen wie Holz, Isoliermaterial, Textilien oder Kunststoffen beigefügt, um ein Entflammen und die Rauchbildung durch Feuer zu unterdrücken oder zu verzögern. Das Marktwachstum für EcoChem Produkte resultiert maßgeblich aus dem gestiegenen Interesse für Brandschutzthemen von Aufsichtsbehörden und Versicherungsgesellschaften. Jedes Jahr fordern die weltweit gemeldeten Brandfälle Schätzungen zufolge rund 80.000 Todesopfer und 800.000 Verle tzte. Die Kosten für Feuerschäden und Schäden durch Rauch und Löschwasser werden auf rund 400 Mrd. EUR geschätzt, und dürften durch die zunehmende Verbauung von brennbaren Materialien und elektronischen Geräten weiter ansteigen. EcoChems Produkte profitieren zudem vom wachsenden Umweltbewusstsein und stellen eine umweltfreundliche Alternative zu halogenierten Produkten dar.

Das im Jahr 2000 von Herman Meynaerts und Pieter Daeseleire gegründete Unternehmen kann ein stetiges Wachstum vorweisen, erwirtschaftet rund 25 Mio. EUR Jahresumsatz und bedient Kunden in 25 Ländern. Neben dem Hauptsitz in Olen (Belgien) hat das Unternehmen zwei Produktionsstandorte in Willebroek (Belgien) und Offenbach (Deutschland).

Der Erfolg des Unternehmens liegt vor allem im einzigartigen Marktansatz und in der ausgeprägten Kundennähe begründet. EcoChem entwickelt Produkte, die sich nahtlos in die Produktionsprozesse der Kunden einfügen. Dank seiner hohen F&E-Kompetenz, dem soliden technischen Know-how und dem fundierten Prozesswissen kann das Unternehmen maßgeschneiderte Produkte anbieten. Als anerkannter Spezialzulieferer der renommiertesten Hersteller von Holzwerkstoffplatten ist EcoChem klarer Marktführer in der Entwicklung und Vermarktung von flammhemmenden Additiven für Spanplatten und andere Holzwerkstoffplatten, die häufig in öffentlichen Gebäuden wie Flughäfen, Hotels und Krankenhäusern zum Einsatz kommen.

Joris Coppye, ehemaliger CEO des Spezialchemievermarkters Azelis und Partner bei der M&A-Beratung Common Ground, kommt mit dem Ziel zu EcoChem, die Wachstumspläne des Unternehmens weiterzuentwickeln: „Auf Basis der Erfolgsbilanz von Pieter Daeseleire und Herman Meynaerts ist es jetzt an der Zeit, EcoChem auf die nächste Expansionsstufe zu heben. Wir freuen uns sehr, mit Gimv einen starken Finanzpartner und Mehrheitseigentümer zu bekommen, der voll und ganz hinter unseren Wachstumsplänen steht. Durch den Zugang zum Board und zum internationalen Branchennetzwerk von Gimv werden wir noch schneller wachsen können.“

Matthias Vandepitte, Principal bei Gimv, fügt hinzu: „Wir freuen uns, dass wir EcoChem bei seiner ehrgeizigen Wachstumsstrategie unterstützen können. Ziel dieser Partnerschaft ist es, EcoChems Marktstellung weiter zu stärken, neue Märkte zu erschließen und das Geschäft auf globaler Ebene auszuweiten. Zukunftsorientierte Nischen in der Spezialchemie bilden einen der zentralen Investmentschwerpunkte unserer Sustainable-Cities-Plattform, und wir freuen uns auf weitere Investitionen in diesem Bereich.“

Die Transaktion tritt nach Zustimmung der deutschen Wettbewerbsbehörden in Kraft.

[R-BgO]

Kurs zur Abwechslung mal > Buchwert

[R-BgO]

Gimv & other shareholders enter into an agreement for the sale of energy distributor Lampiris to Total

Topic: Divestment

Gimv, together with co-investor SRIW and the founding shareholders Bruno Venanzi and Bruno Vanderschueren, have agreed to sell 100% of Lampiris to Total, the world’s fourth-largest oil and gas company and second-largest solar energy operator. Gimv, through its Gimv-XL Fund, was involved as an investor in the company since 2013.

Founded in 2003 by Bruno Venanzi and Bruno Vanderschueren, Lampiris (www.lampiris.be) is an independent distributor of electricity and gas in the Belgian market with about 850,000 connections. Since Gimv became a shareholder in 2013, Lampiris also started operations in France, where it developed into a fast growing challenger with today about 200,000 connections. Moreover, it now also offers insulation services, wood pellets and firewood, smart thermostats or boiler maintenance to its customers.

A strong platform for further expansion into the Belgian and French B2C markets

Given stabilizing market shares and potential economies of scale, a consolidation phase was expected to emerge in the market. Lampiris and its shareholders have actively explored the merits of such consolidation scenarios. The transaction that is announced today fits into Total’s ambition to strengthen its integrated model across the chain of gas and electricity and thus move closer to the end customer. With a portfolio of more than one million customers, Lampiris brings Total a deep customer relation expertise as well as a powerful digital platform.

Dirk Dewals, Partner Gimv, on this transaction: “Over the past years, Lampiris grew from an entrepreneurial challenger in the Belgian energy market into a professional energy distributor, with a strong market position, an attractive client portfolio, and an attractive product offering. The acquisition by Total offers Lampiris a unique opportunity to further expand and grow, backed by a strong industrial group which is rapidly expanding its integrated offering on the gas and renewable electricity market. We are proud to have actively contributed to this transition and would like to thank our co-shareholders and the management team for the fruitful co-operation."

For Gimv, this exit will have a net positive impact of EUR 3.5 million on the equity value at 31 March 2016. Over the entire period, this investment generated a return above Gimv’s long-term average return. No further financial details on this transaction will be disclosed.

[R-BgO]

Antwort auf Beitrag Nr.: 52.315.366 von R-BgO am 30.04.16 10:56:13

Diagnostics company Multiplicom to be acquired by Agilent Technologies

Topic: Investment

Multiplicom, a leading diagnostics company with state-of-the-art genetic testing technology and products, signed an agreement with Agilent Technologies Inc. (NYSE: A) under which Agilent will fully acquire Multiplicom.

Multiplicom was founded in 2011 as a spin-off of the University of Antwerp and of the research institute VIB. It is specialized in the development, manufacturing and commercialization of molecular diagnostic solutions that enable clinical laboratories to identify the DNA variants associated with a genetic disease or predisposition, the results of which may be used to improve cancer therapy selection or identify congenital defects early in pregnancy.

In 2012, Multiplicom was the first diagnostic company in Europe to be awarded CE certification for its test to detect genetic defects that might indicate an increased risk of breast or ovarian cancer. Joining Agilent, a global leader in life sciences, diagnostics and applied chemical markets, opens the opportunity for Multiplicom to offer its products and technology to a global customer base.

Both in April 2011 and February 2013, Gimv and Biotech Fonds Vlaanderen (BFV) acted as lead-investors in both the series A and series B round of Multiplicom, which totaled EUR 7.7 million. Also after the transfer of the management of BFV earlier this year, Gimv kept managing the combined stake of 42% in Multiplicom (1/3 Gimv – 2/3 BFV).

Christophe Van Vaeck, Principal in Gimv’s Health & Care team, comments: “Multiplicom was VIB’s sixth startup and was basically co-created by Gimv. Both our continued financial support and deep involvement enabled the company to develop its innovative diagnostic tests, in getting CE-marking for its test kits, and in building a sales network in the EU. I would like to thank the management team, which played a crucial role in the development and growth of the company. We are very proud that we could partner in this successful trajectory from spin-out to a leading European diagnostics company, now to be continued on a worldwide scale.”

The transaction is expected to close in the first quarter of the 2017 calendar year. Over the entire holding period, this investment generated a return well above Gimv’s long-term average return, though with only a limited additional positive impact on the equity value at 30 September 2016.

For further information, we refer to the joint press release of Agilent and Multiplicom.

[R-BgO]

Luciad, a leading provider of high performance geospatial situational awareness technology that powers the world’s mission critical operations, today announces that it has been acquired by Hexagon AB, a global provider of information technologies that drives productivity and quality across geospatial and industrial enterprise applications.

Luciad (www.luciad.com) was founded in 1999 as a spin-off from the University KU Leuven. Luciad’s applications simplify the lives of developers and end users with advanced visual analytics that allow them to unlock the potential of real time location intelligence and create the foundation for next generation geospatial systems. From safeguarding critical assets to creating the digital infrastructure for smart cities, Luciad helps users implement intuitive command and control systems. Its customers depend on the company for high performance visualization that allows them to implement scalable solutions. Today, the company serves clients worldwide through a network of subsidiaries and resellers in Europe, Asia and the Americas. In addition, major systems integrators incorporate Luciad’s software in their own products. Airbus Defence & Space, Boeing, Dassault, Lufthansa Systems, NATO and Unifly belong to the company’s custom ers.

Gimv, together with co-investor Gimv Arkiv Tech Fund II and the other shareholders today sold their stake in Luciad to the Swedish-headquartered Hexagon (Nasdaq Stockholm: HEXA B), which generates revenues of EUR 3.2 billion with 18.000 employees. Luciad will become a fully owned subsidiary of Hexagon and will operate under its Geospatial division. The company’s products perfectly combine with the offering from Hexagon. Therefore, we see Hexagon as the right partner to unlock the full potential of Luciad’s technology.

Since Gimv’s initial investment in spring 2013, the company’s references and proof concepts for big data applications have contributed to the strategic value of the technology. Over the past years, the company’s products evolved significantly, being from desktop only to web based, into 3D. Moreover, server capacity was added to its offering.

“Gimv has given us the platform we needed to evolve from startup to scale-up. During the 4 years that we were part of Gimv’s portfolio, the organization has grown significantly without experiencing the growth pains that characterize this coming into adulthood for companies,” said Marc Melviez, CEO of Luciad.

Tom Van de Voorde, Head of Gimv‘s Smart Industries platform and board member of Luciad comments: “We are delighted to have found a harbor for Luciad that will be stimulating and synergetic beyond the current standalone potential. Hexagon’s clients will benefit from Luciad’s world class geospatial software allowing them to use geospatial data in making excellent business decisions. During our investment period within Luciad, we have seen Luciad evolve from a timid software player to the leading player in its field thanks to excellent new product releases and hard work of the Luciad employees to establish Luciad as a brand of excellence in some of its verticals. Hexagon understood and experienced Luciad’s power resulting in this transaction.”

Luciad was the first investment of the Smart Industries team after the lauch of Gimv’s platform strategy back in late 2012. Over the entire holding period, the investment in Luciad generated a return well above Gimv’s long-term average return, with a positive impact on the equity value at 30 June 2017 of about EUR 0.75 per Gimv-share. No further details about this transaction will be disclosed.

[R-BgO]

Antwort auf Beitrag Nr.: 55.886.200 von R-BgO am 05.10.17 14:15:17

Thread: Hexagon AB

[R-BgO]

Divi bleibt konstant

[R-BgO]

another solid year

[Huusmeister]

ruhig ist es hier....